-
1
-
-
84872651840
-
Mucormycosis and entomophthoramycosis (zygomycosis)
-
In Kauffman CA, Pappas PG, Sobel JD, Dismukes WE (ed), 2nd ed. Springer, New York, NY
-
Ibrahim AS, Edwards JE, Jr, Filler SG, Spellberg B. 2011. Mucormycosis and entomophthoramycosis (zygomycosis), p 265-280. In Kauffman CA, Pappas PG, Sobel JD, Dismukes WE (ed), Essentials of clinical mycology, 2nd ed. Springer, New York, NY.
-
(2011)
Essentials of Clinical Mycology
, pp. 265-280
-
-
Ibrahim, A.S.1
Edwards Jr., J.E.2
Filler, S.G.3
Spellberg, B.4
-
2
-
-
0001988401
-
Mucormycosis
-
Lea & Febiger, Philadelphia, PA
-
Kwon-Chung KJ, Bennett JE. 1992. Mucormycosis, p 524-559. In Medical mycology. Lea & Febiger, Philadelphia, PA.
-
(1992)
Medical Mycology
, pp. 524-559
-
-
Kwon-Chung, K.J.1
Bennett, J.E.2
-
3
-
-
22244468107
-
Agents of mucormycosis and related species
-
In Mandell GL, Bennett JE, Dolin R (ed), 6th ed. Elsevier, Philadelphia, PA
-
Sugar AM. 2005. Agents of mucormycosis and related species, p 2979. In Mandell GL, Bennett JE, Dolin R (ed), Principles and practice of infectious diseases, 6th ed. Elsevier, Philadelphia, PA.
-
(2005)
Principles and Practice of Infectious Diseases
, pp. 2979
-
-
Sugar, A.M.1
-
4
-
-
84870522923
-
Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011
-
Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, Etienne K, Deak E, Derado G, Shieh WJ, Drew C, Zaki S, Sugerman D, Gade L, Thompson EH, Sutton DA, Engelthaler DM, Schupp JM, Brandt ME, Harris JR, Lockhart SR, Turabelidze G, Park BJ. 2012. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N. Engl. J. Med. 367:2214-2225.
-
(2012)
N. Engl. J. Med.
, vol.367
, pp. 2214-2225
-
-
Neblett Fanfair, R.1
Benedict, K.2
Bos, J.3
Bennett, S.D.4
Lo, Y.C.5
Adebanjo, T.6
Etienne, K.7
Deak, E.8
Derado, G.9
Shieh, W.J.10
Drew, C.11
Zaki, S.12
Sugerman, D.13
Gade, L.14
Thompson, E.H.15
Sutton, D.A.16
Engelthaler, D.M.17
Schupp, J.M.18
Brandt, M.E.19
Harris, J.R.20
Lockhart, S.R.21
Turabelidze, G.22
Park, B.J.23
more..
-
5
-
-
14744285035
-
Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka
-
DOI 10.1016/S0140-6736(05)71046-1
-
Andresen D, Donaldson A, Choo L, Knox A, Klaassen M, Ursic C, Vonthethoff L, Krilis S, Konecny P. 2005. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 365:876-878. (Pubitemid 40332166)
-
(2005)
Lancet
, vol.365
, Issue.9462
, pp. 876-878
-
-
Andresen, D.1
Donaldson, A.2
Choo, L.3
Knox, A.4
Klaassen, M.5
Ursic, C.6
Vonthethoff, L.7
Krilis, S.8
Konecny, P.9
-
7
-
-
22244466058
-
Novel perspectives on mucormycosis: Pathophysiology, presentation, and management
-
DOI 10.1128/CMR.18.3.556-569.2005
-
Spellberg B, Edwards J, Jr, Ibrahim JA. 2005. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin. Microbiol. Rev. 18:556-569. (Pubitemid 40995116)
-
(2005)
Clinical Microbiology Reviews
, vol.18
, Issue.3
, pp. 556-569
-
-
Spellberg, B.1
Edwards Jr., J.2
Ibrahim, A.3
-
8
-
-
73249149842
-
Invasive zygomycosis in India: Experience in a tertiary care hospital
-
Chakrabarti A, Chatterjee SS, Das A, Panda N, Shivaprakash MR, Kaur A, Varma SC, Singhi S, Bhansali A, Sakhuja V. 2009. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad. Med. J. 85:573-581.
-
(2009)
Postgrad. Med. J.
, vol.85
, pp. 573-581
-
-
Chakrabarti, A.1
Chatterjee, S.S.2
Das, A.3
Panda, N.4
Shivaprakash, M.R.5
Kaur, A.6
Varma, S.C.7
Singhi, S.8
Bhansali, A.9
Sakhuja, V.10
-
9
-
-
0036532203
-
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
-
DOI 10.1086/339202
-
Marr KA, Carter RA, Crippa F, Wald A, Corey L. 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis. 34:909-917. (Pubitemid 34229758)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.7
, pp. 909-917
-
-
Marr, K.A.1
Carter, R.A.2
Crippa, F.3
Wald, A.4
Corey, L.5
-
10
-
-
84855901057
-
Healthcare-associated mucormycosis
-
Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O. 2012. Healthcare-associated mucormycosis. Clin. Infect. Dis. 54(Suppl 1):S44-S54.
-
(2012)
Clin. Infect. Dis.
, vol.54
, Issue.SUPPL. 1
-
-
Rammaert, B.1
Lanternier, F.2
Zahar, J.R.3
Dannaoui, E.4
Bougnoux, M.E.5
Lecuit, M.6
Lortholary, O.7
-
12
-
-
23844464106
-
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
-
DOI 10.1086/432579
-
Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ. 2005. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin. Infect. Dis. 41:634-653. (Pubitemid 41170352)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.5
, pp. 634-653
-
-
Roden, M.M.1
Zaoutis, T.E.2
Buchanan, W.L.3
Knudsen, T.A.4
Sarkisova, T.A.5
Schaufele, R.L.6
Sein, M.7
Sein, T.8
Chiou, C.C.9
Chu, J.H.10
Kontoyiannis, D.P.11
Walsh, T.J.12
-
13
-
-
80055000208
-
The emerging epidemiology of mould infections in developing countries
-
Chakrabarti A, Singh R. 2011. The emerging epidemiology of mould infections in developing countries. Curr. Opin. Infect. Dis. 24:521-526.
-
(2011)
Curr. Opin. Infect. Dis.
, vol.24
, pp. 521-526
-
-
Chakrabarti, A.1
Singh, R.2
-
14
-
-
79955062077
-
Mucormycosis caused by unusual mucormycetes, non-Rhizopus,-Mucor, and-Lichtheimia species
-
Gomes MZ, Lewis RE, Kontoyiannis DP. 2011. Mucormycosis caused by unusual mucormycetes, non-Rhizopus,-Mucor, and-Lichtheimia species. Clin. Microbiol. Rev. 24:411-445.
-
(2011)
Clin. Microbiol. Rev.
, vol.24
, pp. 411-445
-
-
Gomes, M.Z.1
Lewis, R.E.2
Kontoyiannis, D.P.3
-
15
-
-
71549171715
-
Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: Rehabilitation of L. ramosa
-
Garcia-Hermoso D, Hoinard D, Gantier JC, Grenouillet F, Dromer F, Dannaoui E. 2009. Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa. J. Clin. Microbiol. 47:3862-3870.
-
(2009)
J. Clin. Microbiol.
, vol.47
, pp. 3862-3870
-
-
Garcia-Hermoso, D.1
Hoinard, D.2
Gantier, J.C.3
Grenouillet, F.4
Dromer, F.5
Dannaoui, E.6
-
16
-
-
84855869146
-
Epidemiology and clinical manifestations of mucormycosis
-
Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. 2012. Epidemiology and clinical manifestations of mucormycosis. Clin. Infect. Dis. 54(Suppl 1):S23-S34.
-
(2012)
Clin. Infect. Dis.
, vol.54
, Issue.SUPPL. 1
-
-
Petrikkos, G.1
Skiada, A.2
Lortholary, O.3
Roilides, E.4
Walsh, T.J.5
Kontoyiannis, D.P.6
-
17
-
-
79955524549
-
Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
-
Skiada A, Pagano L, Groll A, Zimmerli S, Dupont B, Lagrou K, Lass-Florl C, Bouza E, Klimko N, Gaustad P, Richardson M, Hamal P, Akova M, Meis JF, Rodriguez-Tudela JL, Roilides E, Mitrousia-Ziouva A, Petrikkos G. 2011. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin. Microbiol. Infect. 17:1859-1867.
-
(2011)
Clin. Microbiol. Infect.
, vol.17
, pp. 1859-1867
-
-
Skiada, A.1
Pagano, L.2
Groll, A.3
Zimmerli, S.4
Dupont, B.5
Lagrou, K.6
Lass-Florl, C.7
Bouza, E.8
Klimko, N.9
Gaustad, P.10
Richardson, M.11
Hamal, P.12
Akova, M.13
Meis, J.F.14
Rodriguez-Tudela, J.L.15
Roilides, E.16
Mitrousia-Ziouva, A.17
Petrikkos, G.18
-
18
-
-
78650293086
-
Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient
-
Ashkenazi-Hoffnung L, Bilavsky E, Avitzur Y, Amir J. 2010. Successful treatment of cutaneous zygomycosis with intravenous amphotericin B followed by oral posaconazole in a multivisceral transplant recipient. Transplantation 90:1133-1135.
-
(2010)
Transplantation
, vol.90
, pp. 1133-1135
-
-
Ashkenazi-Hoffnung, L.1
Bilavsky, E.2
Avitzur, Y.3
Amir, J.4
-
19
-
-
84872762137
-
Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports
-
Hsieh TT, Tseng HK, Sun PL, Wu YH, Chen GS. 2013. Disseminated zygomycosis caused by Cunninghamella bertholletiae in patient with hematological malignancy and review of published case reports. Mycopathologia 175:99-106.
-
(2013)
Mycopathologia
, vol.175
, pp. 99-106
-
-
Hsieh, T.T.1
Tseng, H.K.2
Sun, P.L.3
Wu, Y.H.4
Chen, G.S.5
-
20
-
-
79551679695
-
Thyroid involvement in disseminated zygomycosis by Cunninghamella bertholletiae: 2 cases and literature review
-
Mayayo E, Klock C, Goldani L. 2011. Thyroid involvement in disseminated zygomycosis by Cunninghamella bertholletiae: 2 cases and literature review. Int. J. Surg. Pathol. 19:75-79.
-
(2011)
Int. J. Surg. Pathol.
, vol.19
, pp. 75-79
-
-
Mayayo, E.1
Klock, C.2
Goldani, L.3
-
21
-
-
2542637821
-
Improved outcome of zygomycosis in patients with hematological diseases?
-
DOI 10.1080/10428190310001653691
-
Gleissner B, Schilling A, Anagnostopolous I, Siehl I, Thiel E. 2004. Improved outcome of zygomycosis in patients with hematological diseases? Leuk. Lymphoma 45:1351-1360. (Pubitemid 38701909)
-
(2004)
Leukemia and Lymphoma
, vol.45
, Issue.7
, pp. 1351-1360
-
-
Gleissner, B.1
Schilling, A.2
Anagnostopolous, I.3
Siehl, I.4
Thiel, E.5
-
22
-
-
4344627134
-
Zygomycosis: Reemergence of an old pathogen
-
DOI 10.1086/422729
-
Kauffman CA. 2004. Zygomycosis: reemergence of an old pathogen. Clin. Infect. Dis. 39:588-590. (Pubitemid 39120941)
-
(2004)
Clinical Infectious Diseases
, vol.39
, Issue.4
, pp. 588-590
-
-
Kauffman, C.A.1
-
23
-
-
0034464807
-
Zygomycosis in the 1990s in a tertiary-care cancer center
-
DOI 10.1086/313803
-
Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV. 2000. Zygomycosis in the 1990s in a tertiary-care cancer center. Clin. Infect. Dis. 30:851-856. (Pubitemid 32250321)
-
(2000)
Clinical Infectious Diseases
, vol.30
, Issue.6
, pp. 851-856
-
-
Kontoyiannis, D.P.1
Wessel, V.C.2
Bodey, G.P.3
Rolston, K.V.I.4
-
24
-
-
0041766322
-
Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi
-
DOI 10.1086/375822
-
Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, Jacobs R, Dominguez EA, Tollemar JG, Baumgarten K, Yu CM, Wagener MM, Linden P, Kusne S, Singh N. 2003. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin. Infect. Dis. 37:221-229. (Pubitemid 36930353)
-
(2003)
Clinical Infectious Diseases
, vol.37
, Issue.2
, pp. 221-229
-
-
Husain, S.1
Alexander, B.D.2
Munoz, P.3
Avery, R.K.4
Houston, S.5
Pruett, T.6
Jacobs, R.7
Dominguez, E.A.8
Tollemar, J.G.9
Baumgarten, K.10
Yu, C.M.11
Wagener, M.M.12
Linden, P.13
Kusne, S.14
Singh, N.15
-
25
-
-
0141993976
-
Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae
-
DOI 10.1128/AAC.47.10.3343-3344.2003
-
Ibrahim AS, Avanessian V, Spellberg B, Edwards JE, Jr. 2003. Liposomal amphotericin B, and not amphotericin B deoxycholate, improves survival of diabetic mice infected with Rhizopus oryzae. Antimicrob. Agents Chemother. 47:3343-3344. (Pubitemid 37229602)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.10
, pp. 3343-3344
-
-
Ibrahim, A.S.1
Avanessian, V.2
Spellberg, B.3
Edwards Jr., J.E.4
-
26
-
-
34848831462
-
The iron chelator deferasirox protects mice from mucormycosis through iron starvation
-
DOI 10.1172/JCI32338
-
Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz Skory JCD, Edwards JE, Spellberg BJ. 2007. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J. Clin. Invest. 117:2649-2657. (Pubitemid 47494365)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.9
, pp. 2649-2657
-
-
Ibrahim, A.S.1
Gebermariam, T.2
Fu, Y.3
Lin, L.4
Husseiny, M.I.5
French, S.W.6
Schwartz, J.7
Skory, C.D.8
Edwards Jr., J.E.9
Spellberg, B.J.10
-
27
-
-
59749087323
-
Posaconazole mono-or combination therapy for treatment of murine zygomycosis
-
Ibrahim AS, Gebremariam T, Schwartz JA, Edwards JE, Jr, Spellberg B. 2009. Posaconazole mono-or combination therapy for treatment of murine zygomycosis. Antimicrob. Agents Chemother. 53:772-775.
-
(2009)
Antimicrob. Agents Chemother
, vol.53
, pp. 772-775
-
-
Ibrahim, A.S.1
Gebremariam, T.2
Schwartz, J.A.3
Edwards Jr., J.E.4
Spellberg, B.5
-
28
-
-
0021247140
-
Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus
-
Waldorf AR, Ruderman N, Diamond RD. 1984. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J. Clin. Invest. 74:150-160. (Pubitemid 14086055)
-
(1984)
Journal of Clinical Investigation
, vol.74
, Issue.1
, pp. 150-160
-
-
Waldorf, A.R.1
Ruderman, N.2
Diamond, R.D.3
-
29
-
-
65649120359
-
Increased virulence of Zygomycetes organisms following exposure to voriconazole: A study involving fly and murine models of zygomycosis
-
Lamaris GA, Ben-Ami R, Lewis RE, Chamilos G, Samonis G, Kontoyiannis DP. 2009. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis. J. Infect. Dis. 199:1399-1406.
-
(2009)
J. Infect. Dis.
, vol.199
, pp. 1399-1406
-
-
Lamaris, G.A.1
Ben-Ami, R.2
Lewis, R.E.3
Chamilos, G.4
Samonis, G.5
Kontoyiannis, D.P.6
-
30
-
-
0021348616
-
Cerebral mucormycosis in diabetic mice after intrasinus challenge
-
Waldorf AR, Diamond RD. 1984. Cerebral mucormycosis in diabetic mice after intrasinus challenge. Infect. Immun. 44:194-195. (Pubitemid 14165164)
-
(1984)
Infection and Immunity
, vol.44
, Issue.1
, pp. 194-195
-
-
Waldorf, A.R.1
Diamond, R.D.2
-
31
-
-
42049102175
-
Combination echinocandin-polyene treatment of murine mucormycosis
-
DOI 10.1128/AAC.01458-07
-
Ibrahim AS, Gebremariam T, Fu Y, Edwards JE, Jr, Spellberg B. 2008. Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrob. Agents Chemother. 52:1556-1558. (Pubitemid 351522035)
-
(2008)
Antimicrobial Agents and Chemotherapy
, vol.52
, Issue.4
, pp. 1556-1558
-
-
Ibrahim, A.S.1
Gebremariam, T.2
Fu, Y.3
Edwards Jr., J.E.4
Spellberg, B.5
-
32
-
-
0035984835
-
In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model
-
DOI 10.1128/AAC.46.7.2310-2312.2002
-
Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR. 2002. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob. Agents Chemother. 46:2310-2312. (Pubitemid 34665939)
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, Issue.7
, pp. 2310-2312
-
-
Sun, Q.N.1
Najvar, L.K.2
Bocanegra, R.3
Loebenberg, D.4
Graybill, J.R.5
-
33
-
-
0021674517
-
In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus
-
Waldorf AR, Levitz SM, Diamond RD. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis. 150:752-760. (Pubitemid 15200085)
-
(1984)
Journal of Infectious Diseases
, vol.150
, Issue.5
, pp. 752-760
-
-
Waldorf, A.R.1
Levitz, S.M.2
Diamond, R.D.3
-
34
-
-
0025080087
-
Effects of iron and desferrioxamine on Rhizopus infection
-
DOI 10.1007/BF00446996
-
Abe F, Inaba H, Katoh T, Hotchi M. 1990. Effects of iron and desferrioxamine on Rhizopus infection. Mycopathologia 110:87-91. (Pubitemid 20297114)
-
(1990)
Mycopathologia
, vol.110
, Issue.2
, pp. 87-91
-
-
Abe, F.1
Inaba, H.2
Katoh, T.3
Hotchi, M.4
-
35
-
-
0027160171
-
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection: In vitro and in vivo animal studies
-
Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, Van Landuyt HW, Schneider YJ. 1993. Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J. Clin. Invest. 91:1979-1986. (Pubitemid 23141469)
-
(1993)
Journal of Clinical Investigation
, vol.91
, Issue.5
, pp. 1979-1986
-
-
Boelaert, J.R.1
De Locht, M.2
Van Cutsem, J.3
Kerrels, V.4
Cantinieaux, B.5
Verdonck, A.6
Van Landuyt, H.W.7
Schneider, Y.-J.8
-
36
-
-
0028265836
-
Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect
-
Boelaert JR, Van Cutsem J, de Locht M, Schneider YJ, Crichton RR. 1994. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 45:667-671. (Pubitemid 24094476)
-
(1994)
Kidney International
, vol.45
, Issue.3
, pp. 667-671
-
-
Boelaert, J.R.1
Van Cutsem, J.2
De Locht, M.3
Schneider, Y.-J.4
Crichton, R.R.5
-
37
-
-
0242290927
-
Activity of Posaconazole in Treatment of Experimental Disseminated Zygomycosis
-
DOI 10.1128/AAC.47.11.3647-3650.2003
-
Dannaoui E, Meis JF, Loebenberg D, Verweij PE. 2003. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob. Agents Chemother. 47:3647-3650. (Pubitemid 37345740)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.11
, pp. 3647-3650
-
-
Dannaoui, E.1
Meis, J.F.G.M.2
Loebenberg, D.3
Verweij, P.E.4
-
38
-
-
84856967582
-
The Deferasirox-Am Bisome Therapy for Mucormycosis (DEFEAT Mucor) study: A randomized, double-blinded, placebo-controlled trial
-
Spellberg B, Ibrahim AS, Chin-Hong PV, Kontoyiannis DP, Morris MI, Perfect JR, Fredricks D, Brass EP. 2012. The Deferasirox-Am Bisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J. Antimicrob. Chemother. 67:715-722.
-
(2012)
J. Antimicrob. Chemother
, vol.67
, pp. 715-722
-
-
Spellberg, B.1
Ibrahim, A.S.2
Chin-Hong, P.V.3
Kontoyiannis, D.P.4
Morris, M.I.5
Perfect, J.R.6
Fredricks, D.7
Brass, E.P.8
-
39
-
-
42049099662
-
Comparison of lipid amphotericin B preparations in treating murine zygomycosis
-
DOI 10.1128/AAC.01488-07
-
Ibrahim AS, Gebremariam T, Husseiny MI, Stevens DA, Fu Y, Edwards JE, Jr, Spellberg B. 2008. Comparison of lipid amphotericin B preparations in treating murine zygomycosis. Antimicrob. Agents Chemother. 52:1573-1576. (Pubitemid 351522040)
-
(2008)
Antimicrobial Agents and Chemotherapy
, vol.52
, Issue.4
, pp. 1573-1576
-
-
Ibrahim, A.S.1
Gebremariam, T.2
Husseiny, M.I.3
Stevens, D.A.4
Fu, Y.5
Edwards Jr., J.E.6
Spellberg, B.7
-
40
-
-
34548094015
-
P53 aerosol formulationwith low toxicity and high efficiency for early lung cancer treatment
-
DOI 10.1158/1078-0432.CCR-07-0395
-
Zou Y, Tornos C, Qiu X, Lia M, Perez-Soler R. 2007. p53 aerosol formulation with low toxicity and high efficiency for early lung cancer treatment. Clin. Cancer Res. 13:4900-4908. (Pubitemid 47294798)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.16
, pp. 4900-4908
-
-
Zou, Y.1
Tornos, C.2
Qiu, X.3
Lia, M.4
Perez-Soler, R.5
-
41
-
-
0032486794
-
Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes
-
Zou Y, Zong G, Ling YH, Hao MM, Lozano G, Hong WK, Perez-Soler R. 1998. Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes. J. Natl. Cancer Inst. 90:1130-1137. (Pubitemid 28380717)
-
(1998)
Journal of the National Cancer Institute
, vol.90
, Issue.15
, pp. 1130-1137
-
-
Zou, Y.1
Zong, G.2
Ling, Y.-H.3
Hao, M.M.4
Lozano, G.5
Hong, W.K.6
Perez-Soler, R.7
-
42
-
-
12944300987
-
Caspofungin inhibits Rhizopus oryzae 1,3-β-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis
-
DOI 10.1128/AAC.49.2.721-727.2005
-
Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE, Jr, Douglas CM. 2005. Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob. Agents Chemother. 49:721-727. (Pubitemid 40175685)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.2
, pp. 721-727
-
-
Ibrahim, A.S.1
Bowman, J.C.2
Avanessian, V.3
Brown, K.4
Spellberg, B.5
Edwards Jr., J.E.6
Douglas, C.M.7
-
43
-
-
0035188628
-
Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: Demonstration of efficacy of caspofungin acetate
-
DOI 10.1128/AAC.45.12.3474-3481.2001
-
Bowman JC, Abruzzo GK, Anderson JW, Flattery AM, Gill CJ, Pikounis VB, Schmatz DM, Liberator PA, Douglas CM. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 45:3474-3481. (Pubitemid 33107865)
-
(2001)
Antimicrobial Agents and Chemotherapy
, vol.45
, Issue.12
, pp. 3474-3481
-
-
Bowman, J.C.1
Abruzzo, G.K.2
Anderson, J.W.3
Flattery, A.M.4
Gill, C.J.5
Pikounis, V.B.6
Schmatz, D.M.7
Liberator, A.8
Douglas, C.M.9
-
44
-
-
77149155947
-
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani
-
Wiederhold NP, Najvar LK, Bocanegra R, Graybill JR, Patterson TF. 2010. Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani. Antimicrob. Agents Chemother. 54:1055-1059.
-
(2010)
Antimicrob. Agents Chemother
, vol.54
, pp. 1055-1059
-
-
Wiederhold, N.P.1
Najvar, L.K.2
Bocanegra, R.3
Graybill, J.R.4
Patterson, T.F.5
-
45
-
-
2142827100
-
Novel Inhalational Murine Model of Invasive Pulmonary Aspergillosis
-
DOI 10.1128/AAC.48.5.1908-1911.2004
-
Sheppard DC, Rieg G, Chiang LY, Filler SG, Edwards JE, Jr, Ibrahim AS. 2004. Novel inhalational murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 48:1908-1911. (Pubitemid 38544412)
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.5
, pp. 1908-1911
-
-
Sheppard, D.C.1
Rieg, G.2
Chiang, L.Y.3
Filler, S.G.4
Edwards Jr., J.E.5
Ibrahim, A.S.6
-
46
-
-
68249097196
-
Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication
-
doi:10.1371/journal.pgen.1000549
-
Ma LJ, Ibrahim AS, Skory C, Grabherr MG, Burger G, Butler M, Elias M, Idnurm A, Lang BF, Sone T, Abe A, Calvo SE, Corrochano LM, Engels R, Fu J, Hansberg W, Kim JM, Kodira CD, Koehrsen MJ, Liu B, Miranda-Saavedra D, O'Leary S, Ortiz-Castellanos L, Poulter R, Rodriguez-Romero J, Ruiz-Herrera J, Shen YQ, Zeng Q, Galagan J, Birren BW, Cuomo Wickes CABL. 2009. Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication. PLoS Genet. 5:e1000549. doi:10.1371/journal.pgen.1000549.
-
(2009)
PLoS Genet.
, vol.5
-
-
Ma, L.J.1
Ibrahim, A.S.2
Skory, C.3
Grabherr, M.G.4
Burger, G.5
Butler, M.6
Elias, M.7
Idnurm, A.8
Lang, B.F.9
Sone, T.10
Abe, A.11
Calvo, S.E.12
Corrochano, L.M.13
Engels, R.14
Fu, J.15
Hansberg, W.16
Kim, J.M.17
Kodira, C.D.18
Koehrsen, M.J.19
Liu, B.20
Miranda-Saavedra, D.21
O'Leary, S.22
Ortiz-Castellanos, L.23
Poulter, R.24
Rodriguez-Romero, J.25
Ruiz-Herrera, J.26
Shen, Y.Q.27
Zeng, Q.28
Galagan, J.29
Birren, B.W.30
Cuomo Wickes, C.A.B.L.31
more..
-
47
-
-
12844268670
-
Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro
-
DOI 10.1128/IAI.73.2.778-783.2005
-
Ibrahim AS, Spellberg B, Avanessian V, Fu Y, Edwards JE, Jr. 2005. Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro. Infect. Immun. 73:778-783. (Pubitemid 40165733)
-
(2005)
Infection and Immunity
, vol.73
, Issue.2
, pp. 778-783
-
-
Ibrahim, A.S.1
Spellberg, B.2
Avanessian, V.3
Fu, Y.4
Edwards Jr., J.E.5
-
48
-
-
77953223063
-
The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice
-
Liu M, Spellberg B, Phan QT, Fu Y, Lee AS, Edwards JE, Jr, Filler SG, Ibrahim AS. 2010. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J. Clin. Invest. 120:1914-1924.
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 1914-1924
-
-
Liu, M.1
Spellberg, B.2
Phan, Q.T.3
Fu, Y.4
Lee, A.S.5
Edwards Jr., J.E.6
Filler, S.G.7
Ibrahim, A.S.8
-
49
-
-
84855870614
-
A global analysis of mucormycosis in France: The Retro Zygo Study (2005-2007)
-
Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O. 2012. A global analysis of mucormycosis in France: the Retro Zygo Study (2005-2007). Clin. Infect. Dis. 54(Suppl 1):S35-S43.
-
(2012)
Clin. Infect. Dis.
, vol.54
, Issue.SUPPL. 1
-
-
Lanternier, F.1
Dannaoui, E.2
Morizot, G.3
Elie, C.4
Garcia-Hermoso, D.5
Huerre, M.6
Bitar, D.7
Dromer, F.8
Lortholary, O.9
-
50
-
-
84864087118
-
Lichtheimia species exhibit differences in virulence potential
-
doi:10.1371/journal.pone.0040908
-
Schwartze VU, Hoffmann K, Nyilasi I, Papp T, Vagvolgyi C, de Hoog S, Voigt K, Jacobsen ID. 2012. Lichtheimia species exhibit differences in virulence potential. PLoS One 7:e40908. doi:10.1371/journal.pone.0040908.
-
(2012)
PLoS One
, vol.7
-
-
Schwartze, V.U.1
Hoffmann, K.2
Nyilasi, I.3
Papp, T.4
Vagvolgyi, C.5
De Hoog, S.6
Voigt, K.7
Jacobsen, I.D.8
-
51
-
-
0038468730
-
Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: Recovery after posaconazole therapy
-
DOI 10.1086/375075
-
Tobon AM, Arango M, Fernandez D, Restrepo A. 2003. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clin. Infect. Dis. 36:1488-1491. (Pubitemid 36702884)
-
(2003)
Clinical Infectious Diseases
, vol.36
, Issue.11
, pp. 1488-1491
-
-
Tobon, A.M.1
Arango, M.2
Fernandez, D.3
Restrepo, A.4
-
52
-
-
33744463904
-
Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
-
van Burik JA, Hare RS, Solomon HF, Corrado ML, Kontoyiannis DP. 2006. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin. Infect. Dis. 42:e61-e65.
-
(2006)
Clin. Infect. Dis.
, vol.42
-
-
Van Burik, J.A.1
Hare, R.S.2
Solomon, H.F.3
Corrado, M.L.4
Kontoyiannis, D.P.5
-
53
-
-
80255126815
-
Posaconazole for the treatment of mucormycosis
-
Enoch DA, Aliyu SH, Sule O, Lewis SJ, Karas JA. 2011. Posaconazole for the treatment of mucormycosis. Int. J. Antimicrob. Agents 38:465-473.
-
(2011)
Int. J. Antimicrob. Agents
, vol.38
, pp. 465-473
-
-
Enoch, D.A.1
Aliyu, S.H.2
Sule, O.3
Lewis, S.J.4
Karas, J.A.5
-
54
-
-
84860115196
-
In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: Poor efficacy of posaconazole
-
Salas V, Pastor FJ, Calvo E, Alvarez E, Sutton DA, Mayayo E, Fothergill AW, Rinaldi MG, Guarro J. 2012. In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole. Antimicrob. Agents Chemother. 56:2246-2250.
-
(2012)
Antimicrob. Agents Chemother
, vol.56
, pp. 2246-2250
-
-
Salas, V.1
Pastor, F.J.2
Calvo, E.3
Alvarez, E.4
Sutton, D.A.5
Mayayo, E.6
Fothergill, A.W.7
Rinaldi, M.G.8
Guarro, J.9
-
55
-
-
84862637859
-
Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis
-
Salas V, Pastor FJ, Calvo E, Sutton DA, Chander J, Mayayo E, Alvarez E, Guarro J. 2012. Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis. J. Antimicrob. Chemother. 67:1712-1715.
-
(2012)
J. Antimicrob. Chemother
, vol.67
, pp. 1712-1715
-
-
Salas, V.1
Pastor, F.J.2
Calvo, E.3
Sutton, D.A.4
Chander, J.5
Mayayo, E.6
Alvarez, E.7
Guarro, J.8
-
56
-
-
84866491362
-
Experimental murine model of disseminated infection by Saksenaea vasiformis: Successful treatment with posaconazole
-
Salas V, Pastor FJ, Calvo E, Sutton D, Garcia-Hermoso D, Mayayo E, Dromer F, Fothergill A, Alvarez E, Guarro J. 2012. Experimental murine model of disseminated infection by Saksenaea vasiformis: successful treatment with posaconazole. Med. Mycol. 50:710-715.
-
(2012)
Med. Mycol.
, vol.50
, pp. 710-715
-
-
Salas, V.1
Pastor, F.J.2
Calvo, E.3
Sutton, D.4
Garcia-Hermoso, D.5
Mayayo, E.6
Dromer, F.7
Fothergill, A.8
Alvarez, E.9
Guarro, J.10
-
57
-
-
77957245496
-
In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility
-
Spreghini E, Orlando F, Giannini D, Barchiesi F. 2010. In vitro and in vivo activities of posaconazole against zygomycetes with various degrees of susceptibility. J. Antimicrob. Chemother. 65:2158-2163.
-
(2010)
J. Antimicrob. Chemother
, vol.65
, pp. 2158-2163
-
-
Spreghini, E.1
Orlando, F.2
Giannini, D.3
Barchiesi, F.4
-
58
-
-
54049146733
-
Posaconazole combined with amphotericin B, an effective therapy for a murine-disseminated infection caused by Rhizopus oryzae
-
Rodriguez MM, Serena C, Marine M, Pastor FJ, Guarro J. 2008. Posaconazole combined with amphotericin B, an effective therapy for a murine-disseminated infection caused by Rhizopus oryzae. Antimicrob. Agents Chemother. 52:3786-3788.
-
(2008)
Antimicrob. Agents Chemother
, vol.52
, pp. 3786-3788
-
-
Rodriguez, M.M.1
Serena, C.2
Marine, M.3
Pastor, F.J.4
Guarro, J.5
-
59
-
-
12244268640
-
In vitro susceptibilities of zygomycetes to conventional and new antifungals
-
DOI 10.1093/jac/dkg020
-
Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. 2003. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J. Antimicrob. Chemother. 51:45-52. (Pubitemid 36163826)
-
(2003)
Journal of Antimicrobial Chemotherapy
, vol.51
, Issue.1
, pp. 45-52
-
-
Dannaoui, E.1
Meletiadis, J.2
Mouton, J.W.3
Meis, J.F.G.M.4
Verweij, P.E.5
Roilides, E.6
Maglaveras, N.7
Abrahamsen, T.8
Gaustad, P.9
Denning, D.W.10
Rodriguez-Tudela, J.L.11
Petrikkos, G.12
-
60
-
-
0036233027
-
In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes
-
DOI 10.1128/AAC.46.5.1581-1582.2002
-
Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. 2002. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob. Agents Chemother. 46:1581-1582. (Pubitemid 34415351)
-
(2002)
Antimicrobial Agents and Chemotherapy
, vol.46
, Issue.5
, pp. 1581-1582
-
-
Sun, Q.N.1
Fothergill, A.W.2
McCarthy, D.I.3
Rinaldi, M.G.4
Graybill, J.R.5
-
62
-
-
0018224077
-
Diabetes and the gut
-
Scarpello JH, Sladen GE. 1978. Diabetes and the gut. Gut 19:1153-1162. (Pubitemid 9087376)
-
(1978)
Gut
, vol.19
, Issue.12
, pp. 1153-1162
-
-
Scarpello, J.H.B.1
Sladen, G.E.2
|